Commissioned by Boehringer Ingelheim Limited
Information intended for healthcare professionals only. This Guidelines card, which summarises Scottish Medicines Consortium (SMC) advice on tiotropium 2.5 microgram inhalation solution, has been initiated by Boehringer Ingelheim Limited. Boehringer Ingelheim Limited has reviewed this card for technical accuracy and regulatory compliance. Boehringer Ingelheim Limited has provided the prescribing information. The SMC has reviewed this card for technical accuracy and permission request only. The SMC was not involved in the production of this card. Prescribing information can be found on page 2 of the card.
If the PDF does not load within 5 seconds, please refresh the page.